November 25, 2022
Shionogi President Isao Teshirogi (left) Shionogi President Isao Teshirogi on November 24 expressed the company’s unflinching confidence about data obtained from its newly approved COVID-19 pill Xocova (ensitrelvir), brushing aside skepticism around what some see as marginal benefits offered by...read more